Skip to main content
Premium Trial:

Request an Annual Quote

At AACR, Hood Sells Promise of Systems Biology, Challenges Others to Participate

ANAHEIM, Calif., April 19 (GenomeWeb News) - Lee Hood gave the Irving Weinstein Foundation Distinguished Lecture at the American Association for Cancer Research annual meeting here yesterday, focusing his hour-long talk on how systems biology relates to predictive, preventive, and personalized medicine.

Hood challenged the audience to get involved in what he contended is a burgeoning field of research. "The question for each one of you is. 'What kind of role are you going to play in a landscape that is changing very rapidly?'" he said.

Hood used his time to give the audience a broad overview of the history and promise of systems biology, as well as to present some data recently generated at the Seattle-based Institute for Systems Biology, which he founded in 2000.

 

"2000 was just exactly the right time to be thinking about systems biology," said Hood, who left the University of Washington to found the institute. The basic premise, he added, is to "understand the elements in a biological system and the interactions between them" using a combination of biology, technology, and computation in a cross-disciplinary scientific environment.

 

The key improvements to which systems biology should contribute on the disease front include using protein- or gene-expression changes for early diagnosis; stratification of disease; new approaches to drug discovery; identification of adverse effects; and better target selection, Hood said.

 

As an example, Hood presented some work done with prostate cancer by scientists at ISB in conjunction with Lynx Therapeutics (now Solexa) and its MPSS technology, which he described as a "digital analysis of the transcriptome." Research into early- and late-stage prostate cancer has revealed significant and measurable differences in protein and gene regulatory networks that could theoretically be used to develop a multiparameter diagnostic panel that would assess a patient's disease progress, he said.

 

Such work -- potentially looking at thousands of changes in proteins -- will not be possible with current technology at current pricing, Hood said. He predicted that it will take a move toward nanotechnology and microfluidics, and eventually doing work on the single-cell level, before this aspect of systems biology has a major clinical impact. To that end, his group is developing a nanotech-based method to measure gene and protein expression as well as protein-DNA and protein-protein interactions.

 

Hood, president of the ISB, was chosen by the AACR president and board to be the first recipient of the Irving Weinstein lecture award. After listing Hood's accomplishments in the field of systems biology, AACR President Lynn Matrisian said, "It's no wonder that cancer researchers are paying close attention to this [approach]."

 

Talks began at the 96th annual AACR meeting on Saturday morning at the AnaheimConvention Center. The conference, which attracts more than 15,000 scientists each year, ends on Wednesday.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.